References
- Murphy TF, Apicella MA. Non-typeable Haemophilus influenzae: a review of clinical aspects, surface antigens, and the human immune response to infection. Rev Infect Dis 1987; 9: 1–15
- Markowitz SM. Isolation of an ampicillin-resistant, non-β-lactamase-producing strain of Haemophilus influenzae. Antimicrob Agents Chemother 1980; 17: 80–3
- Karlowsky JA, Critchley IA, Blosser-Middleton RS, Karginova EA, Jones ME, Thornsberry C, Sahm DF. Antimicrobial surveillance of Haemophilus influenzae in the United States during 2000–2001 leads to detection of clonal dissemination of a beta-lactamase-negative and ampicillin-resistant strain. J Clin Microbiol 2000; 40: 1063–6
- Powell M, McVey D, Kassi MH, Chen HY, Williams JD. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Brahamella) catarrhalis isolated in the UK from sputa. J Antimicrob Chemother 1991; 28: 249–59
- Seki H, Kasahara Y, Ohta K, Saikawa Y, Sumita R, Yachie A, et al. Increasing prevalence of ampicillin-resistant, non-beta-lactamase-producing strains of Haemophilus influenzae in children in Japan. Chemotherapy (Basel) 1999; 45: 15–21
- Ubukata K, Shibasaki Y, Yamamoto K, Chiba N, Hasegawa K, Takeuchi Y, et al. Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in β-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother 2001; 45: 1693–9
- Ubukata K. Problems associated with high prevalence of multi-drug resistant bacteria in patients with community-acquired infections. J Infect Chemother 2003; 9: 285–91
- Suzuki K, Nishimura T, Baba S. Current status of bacterial resistance in the otolaryngology field: results from the second nationwide survey in Japan. J Infect Chemother 2003; 9: 46–52
- Marco, F, Garcia-de-Lomas, J, Garcia-Rey, C, Bouza, E, Aguilar, L, Fernandez-Mazarrzsa, C, Spanish Surveillance Group For Respiratory Pathogens. Antimicrobial susceptibilities of 1730 Haemophilus influenzae respiratory tract isolates in Spain in 1998–1999. Antimicrob Agents Chemother 2001;45:3226–8.
- Hoban D, Felmingham D. The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections. J Antimicrob Chemother 2002; 50: 49–59
- Karlowsky JA, Critchley IA, Blosser-Middleton RS, Karginova EA, Jones ME, Thornsberry C, Sahm DF. Antimicrobial surveillance of Haemophilus influenzae in the United States during 2000–2001 leads to detection of clonal dissemination of a beta-lactamase-negative and ampicillin-resistant strain. J Clin Microbiol 2002; 40: 1063–6
- Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243–50
- Murray TJ, Washington JA. Microscopic and bacteriological analysis of expectorated sputum. Mayo Clin Proc 1975; 50: 339–44
- Suzuki K, Nishimura T, Baba S. Current status of bacterial resistance in the otolaryngology field: results from the Second Nationwide Survey in Japan. J Infect Chemother 2003; 9: 46–52
- Watanabe H, Hoshino K, Sugita R, Asoh N, Watanabe K, Oishi K, Nagatake T. Possible high rate of transmission of non-typeable Haemophilus influenzae, including beta-lactamase-negative ampicillin-resistant strains, between children and their parents. J Clin Microbiol 2004; 42: 362–5